Drug - DPP-4 inhibitors (Kazano®, Nesina®, Oseni®) [Takeda]
October 2013
Therapeutic area - Antihyperglycemics
Kazano®: quantity limit is 68 tablets per 34-day supply
Nesina®: quantity limit is 34 tablets per 34-day supply
Oseni®: quantity limit is 34 tablets per 34-day supply
DPP-4 inhibitors are indicated as an adjunct to diet and exercise to improve glycemic control in patients with Type 2 diabetes.
MHCP Provider Call Center 651-431-2700 or 800-366-5411